BR112014028334A2 - derivados dipeptídicos de lisina ácido glutâmico. - Google Patents
derivados dipeptídicos de lisina ácido glutâmico.Info
- Publication number
- BR112014028334A2 BR112014028334A2 BR112014028334A BR112014028334A BR112014028334A2 BR 112014028334 A2 BR112014028334 A2 BR 112014028334A2 BR 112014028334 A BR112014028334 A BR 112014028334A BR 112014028334 A BR112014028334 A BR 112014028334A BR 112014028334 A2 BR112014028334 A2 BR 112014028334A2
- Authority
- BR
- Brazil
- Prior art keywords
- glutamic acid
- dipeptide derivatives
- lysine glutamic
- lysine
- dipeptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C271/34—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12168119.1 | 2012-05-15 | ||
| EP12168119.1A EP2664374A1 (en) | 2012-05-15 | 2012-05-15 | Lysin-glutamic acid dipeptide derivatives |
| PCT/EP2013/059759 WO2013171135A1 (en) | 2012-05-15 | 2013-05-13 | Lysin-glutamic acid dipeptide derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014028334A2 true BR112014028334A2 (pt) | 2018-05-29 |
| BR112014028334B1 BR112014028334B1 (pt) | 2020-02-27 |
Family
ID=48430764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014028334-6A BR112014028334B1 (pt) | 2012-05-15 | 2013-05-13 | Derivados dipeptídicos de lisina ácido glutâmico |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US9522874B2 (pt) |
| EP (3) | EP2664374A1 (pt) |
| JP (1) | JP6162795B2 (pt) |
| KR (2) | KR102094928B1 (pt) |
| CN (1) | CN104271227B (pt) |
| AR (1) | AR091044A1 (pt) |
| AU (1) | AU2013261894B2 (pt) |
| BR (1) | BR112014028334B1 (pt) |
| CA (2) | CA2868144C (pt) |
| ES (2) | ES2692364T3 (pt) |
| HK (1) | HK1200753A1 (pt) |
| HR (2) | HRP20171058T1 (pt) |
| IL (1) | IL235425B (pt) |
| MX (2) | MX349822B (pt) |
| MY (2) | MY184184A (pt) |
| NZ (1) | NZ631215A (pt) |
| PL (2) | PL3127604T3 (pt) |
| RU (1) | RU2640812C2 (pt) |
| SG (1) | SG11201406888QA (pt) |
| SI (2) | SI2849882T1 (pt) |
| WO (1) | WO2013171135A1 (pt) |
| ZA (1) | ZA201407528B (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA116217C2 (uk) | 2012-10-09 | 2018-02-26 | Санофі | Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону |
| JP2016503771A (ja) | 2012-12-21 | 2016-02-08 | サノフイ | エキセンジン−４誘導体 |
| GB201315335D0 (en) | 2013-08-29 | 2013-10-09 | Of Singapore | Amino diacids containing peptide modifiers |
| EP3080150B1 (en) | 2013-12-13 | 2018-08-01 | Sanofi | Exendin-4 peptide analogues as dual glp-1/gip receptor agonists |
| EP3080154B1 (en) | 2013-12-13 | 2018-02-07 | Sanofi | Dual glp-1/gip receptor agonists |
| EP3080149A1 (en) | 2013-12-13 | 2016-10-19 | Sanofi | Dual glp-1/glucagon receptor agonists |
| WO2015086730A1 (en) | 2013-12-13 | 2015-06-18 | Sanofi | Non-acylated exendin-4 peptide analogues |
| TW201625670A (zh) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | 衍生自ｅｘｅｎｄｉｎ－４之雙重ｇｌｐ－１／升糖素受體促效劑 |
| TW201625668A (zh) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | 作為胜肽性雙重ｇｌｐ－１／昇糖素受體激動劑之艾塞那肽－４衍生物 |
| TW201625669A (zh) | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | 衍生自艾塞那肽－４（Ｅｘｅｎｄｉｎ－４）之肽類雙重ＧＬＰ－１／升糖素受體促效劑 |
| US9932381B2 (en) | 2014-06-18 | 2018-04-03 | Sanofi | Exendin-4 derivatives as selective glucagon receptor agonists |
| AR105319A1 (es) | 2015-06-05 | 2017-09-27 | Sanofi Sa | Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico |
| AR105284A1 (es) | 2015-07-10 | 2017-09-20 | Sanofi Sa | Derivados de exendina-4 como agonistas peptídicos duales específicos de los receptores de glp-1 / glucagón |
| JP6991196B2 (ja) | 2016-03-23 | 2022-02-03 | バッヘン・ホールディング・アクチエンゲゼルシャフト | グルカゴン様ペプチドを製造するための方法 |
| WO2020208409A1 (en) * | 2019-04-10 | 2020-10-15 | Dr. Reddy’S Laboratories Limited | Improved processes for the preparation of peptide intermediates/modifiers |
| CN111454180A (zh) * | 2020-04-10 | 2020-07-28 | 大连阿拉宁生物技术有限公司 | 一种索马鲁肽侧链中间体及其制备方法 |
| CN113004370B (zh) * | 2021-02-09 | 2022-06-17 | 宁波绿之健药业有限公司 | 一种具有缓解高尿酸血症和调节肠道菌群的二肽及其应用 |
| EP4345104A1 (en) | 2022-09-30 | 2024-04-03 | Bachem Holding AG | Method for preparing liraglutide |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU227021B1 (en) * | 1996-08-30 | 2010-05-28 | Novo Nordisk As | Glp-1 derivatives |
| EP1263458B1 (en) * | 2000-03-08 | 2005-11-16 | Novo Nordisk A/S | Lowering serum cholesterol |
| US20060258580A1 (en) * | 2003-05-14 | 2006-11-16 | Regents Of The University Of Michigan | Modulators of Nod1 signaling |
| JP2006233405A (ja) * | 2005-08-16 | 2006-09-07 | Asahi Kasei Chemicals Corp | 繊維処理剤 |
| IE20060841A1 (en) * | 2006-11-21 | 2008-05-28 | Ipsen Mfg Ireland Ltd | Boc and fmoc solid phase peptide synthesis |
| JP2008290987A (ja) * | 2007-05-28 | 2008-12-04 | Shiseido Co Ltd | Ｃｍｃ修復剤、毛髪化粧料およびｃｍｃ修復方法 |
| JP5127316B2 (ja) * | 2007-06-22 | 2013-01-23 | 旭化成ケミカルズ株式会社 | 化学機械研磨用組成物 |
| MY160219A (en) * | 2008-12-15 | 2017-02-28 | Zealand Pharma As | Glucagon analogues |
| EA022816B1 (ru) * | 2009-07-13 | 2016-03-31 | Зилэнд Фарма А/С | Ацилированные аналоги глюкагона |
| JP2011057663A (ja) * | 2009-08-11 | 2011-03-24 | Sumitomo Chemical Co Ltd | 化合物及びフォトレジスト組成物 |
| CN102286092B (zh) * | 2011-09-14 | 2014-01-01 | 深圳翰宇药业股份有限公司 | 利拉鲁肽的固相合成方法 |
| US20130316941A1 (en) * | 2011-12-23 | 2013-11-28 | Boehringer Ingelheim International Gmbh | Glucagon analogues |
-
2012
- 2012-05-15 EP EP12168119.1A patent/EP2664374A1/en not_active Ceased
-
2013
- 2013-05-13 NZ NZ631215A patent/NZ631215A/en unknown
- 2013-05-13 CA CA2868144A patent/CA2868144C/en active Active
- 2013-05-13 EP EP13722408.5A patent/EP2849882B1/en active Active
- 2013-05-13 MX MX2014013505A patent/MX349822B/es active IP Right Grant
- 2013-05-13 WO PCT/EP2013/059759 patent/WO2013171135A1/en active Application Filing
- 2013-05-13 SI SI201330739T patent/SI2849882T1/sl unknown
- 2013-05-13 MY MYPI2018000443A patent/MY184184A/en unknown
- 2013-05-13 EP EP16179885.5A patent/EP3127604B1/en active Active
- 2013-05-13 JP JP2015512007A patent/JP6162795B2/ja active Active
- 2013-05-13 ES ES16179885.5T patent/ES2692364T3/es active Active
- 2013-05-13 KR KR1020197014335A patent/KR102094928B1/ko active IP Right Grant
- 2013-05-13 AU AU2013261894A patent/AU2013261894B2/en active Active
- 2013-05-13 MX MX2017006522A patent/MX363728B/es unknown
- 2013-05-13 MY MYPI2014703386A patent/MY172395A/en unknown
- 2013-05-13 CA CA3096624A patent/CA3096624C/en active Active
- 2013-05-13 BR BR112014028334-6A patent/BR112014028334B1/pt active IP Right Grant
- 2013-05-13 SG SG11201406888QA patent/SG11201406888QA/en unknown
- 2013-05-13 KR KR1020147031824A patent/KR102018160B1/ko active IP Right Grant
- 2013-05-13 ES ES13722408.5T patent/ES2637415T3/es active Active
- 2013-05-13 CN CN201380024470.5A patent/CN104271227B/zh active Active
- 2013-05-13 RU RU2014148530A patent/RU2640812C2/ru active
- 2013-05-13 PL PL16179885T patent/PL3127604T3/pl unknown
- 2013-05-13 SI SI201331208T patent/SI3127604T1/sl unknown
- 2013-05-13 PL PL13722408T patent/PL2849882T3/pl unknown
- 2013-05-14 AR ARP130101662A patent/AR091044A1/es active IP Right Grant
-
2014
- 2014-10-16 ZA ZA2014/07528A patent/ZA201407528B/en unknown
- 2014-10-30 IL IL235425A patent/IL235425B/en active IP Right Grant
- 2014-11-12 US US14/539,126 patent/US9522874B2/en active Active
-
2015
- 2015-02-05 HK HK15101247.2A patent/HK1200753A1/xx unknown
-
2016
- 2016-11-10 US US15/348,093 patent/US9802886B2/en active Active
-
2017
- 2017-07-11 HR HRP20171058TT patent/HRP20171058T1/hr unknown
- 2017-10-11 US US15/730,585 patent/US20180029978A1/en not_active Abandoned
-
2018
- 2018-10-17 HR HRP20181696TT patent/HRP20181696T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014028334A2 (pt) | derivados dipeptídicos de lisina ácido glutâmico. | |
| FR22C1047I2 (fr) | Derives de benzimidazole-proline | |
| DK2890402T3 (da) | Modificerede aminosyrer omfattende en azidogruppe | |
| HK1211569A1 (en) | Amino acid derivatives | |
| UY34602A (es) | ?Derivados de bencimidazolil- e imidazopiridinil-metilamina? | |
| BR112014029261A2 (pt) | compostos de ácido carboxílico | |
| BR112014030064A2 (pt) | composição do ácido carboxílico. | |
| BR112015000507A2 (pt) | inibição de enzimas | |
| AR092198A1 (es) | Derivados de pirazolopirimidinas | |
| DK2900645T3 (da) | Herbicidt aktive 3-phenylisoxazolinderivater | |
| BR112013014615A2 (pt) | produto de base de sabor concentrado | |
| HK1225372A1 (zh) | 氨基酸衍生物 | |
| CO7020919A2 (es) | Derivados de tetrahidro-quinazolinona | |
| FR2995214B1 (fr) | Solution a viscosite reduite de proteine a concentration elevee | |
| CO6900148A2 (es) | Inhibidores de la enzima activadora de nedd8 | |
| CO6960557A2 (es) | Derivados de 2-yodo-imidazol | |
| CU20130003A7 (es) | Procedimiento de preparacion de la sal de l-arginina de perindoprilo. | |
| ES2721400T8 (es) | Composición de Diclofenaco | |
| DK2922414T3 (da) | Mælkeerstatninger omfattende optimerede aminosyreprofiler | |
| BR112013023539A2 (pt) | derivados de isoxazolidina | |
| CO7020920A2 (es) | Derivado de fenilazol sustituido | |
| CO6852074A2 (es) | Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida | |
| CO6862161A2 (es) | Derivados de amida sustituidos con n-hetero-anillo | |
| BR112014028441A2 (pt) | composição de proteína | |
| CO6990727A2 (es) | Derivados de quinolina como inhibidores de la enzima pde10a |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/05/2013, OBSERVADAS AS CONDICOES LEGAIS. |